Further, microbial products are sensed by Toll-like receptors, which trigger MyD88-mediated production of IL-23 proinflammatory cytokine which activates IL-17a, IL-6, and IL-22 release and thus promotes CRC development (111, 112). This evidence concerns the gene IL22 and colorectal carcinoma.